Skip to main content

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy

Publication ,  Journal Article
Okumura, N; Jhund, PS; Gong, J; Lefkowitz, MP; Rizkala, AR; Rouleau, JL; Shi, VC; Swedberg, K; Zile, MR; Solomon, SD; Packer, M; McMurray, JJV
Published in: Circulation: Heart Failure
September 2016

Duke Scholars

Published In

Circulation: Heart Failure

DOI

EISSN

1941-3297

ISSN

1941-3289

Publication Date

September 2016

Volume

9

Issue

9

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology
  • 1116 Medical Physiology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., … McMurray, J. J. V. (2016). Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circulation: Heart Failure, 9(9). https://doi.org/10.1161/circheartfailure.116.003212
Okumura, Naoki, Pardeep S. Jhund, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor C. Shi, et al. “Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.” Circulation: Heart Failure 9, no. 9 (September 2016). https://doi.org/10.1161/circheartfailure.116.003212.
Okumura, Naoki, et al. “Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.” Circulation: Heart Failure, vol. 9, no. 9, Ovid Technologies (Wolters Kluwer Health), Sept. 2016. Crossref, doi:10.1161/circheartfailure.116.003212.
Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJV. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circulation: Heart Failure. Ovid Technologies (Wolters Kluwer Health); 2016 Sep;9(9).

Published In

Circulation: Heart Failure

DOI

EISSN

1941-3297

ISSN

1941-3289

Publication Date

September 2016

Volume

9

Issue

9

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology
  • 1116 Medical Physiology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 0601 Biochemistry and Cell Biology